•] Shares1 Zosana Pharma Corporation Common Stock PURCHASE AGREEMENTPurchase Agreement • January 29th, 2018 • Zosano Pharma Corp • Pharmaceutical preparations • New York
Contract Type FiledJanuary 29th, 2018 Company Industry JurisdictionZosano Pharma Corporation, a Delaware corporation (the “Company”) proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) for whom BTIG, LLC is acting as representative (the “Representative”), an aggregate of [•] shares (the “Firm Shares”) of Common Stock, $0.0001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to an aggregate of [•] additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement (the “Agreement”) are herein called the “Securities.”